Production (Stage)
Verve Therapeutics, Inc.
VERV
$4.36
-$0.02-0.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.19% | -2.90% | -6.26% | -5.02% | -2.82% |
| Total Receivables | -57.02% | 23.86% | -13.55% | -47.29% | -2.20% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.41% | 9.37% | 16.91% | 45.25% | 1.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.73% | -2.46% | -5.83% | -4.75% | -2.76% |
|
|
|||||
| Total Current Assets | -5.73% | -2.46% | -5.83% | -4.75% | -2.76% |
| Net Property, Plant & Equipment | -2.12% | -2.83% | -2.34% | -2.51% | -3.01% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.96% | 0.18% | -2.36% | 8.18% | 7.80% |
| Total Assets | -5.13% | -2.49% | -5.28% | -4.29% | -2.70% |
|
|
|||||
| Total Accounts Payable | 18.41% | -2.52% | -32.14% | 124.11% | -54.05% |
| Total Accrued Expenses | -29.94% | 11.67% | 12.06% | 17.52% | -15.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.71% | 0.71% | 0.73% | 0.71% | 0.27% |
| Total Finance Division Other Current Liabilities | 428.71% | -38.26% | 54.10% | 157.23% | 194.60% |
| Total Other Current Liabilities | 428.71% | -38.26% | 54.10% | 157.23% | 194.60% |
| Total Current Liabilities | 21.14% | 0.63% | 5.64% | 28.99% | -15.44% |
|
|
|||||
| Total Current Liabilities | 21.14% | 0.63% | 5.64% | 28.99% | -15.44% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.39% | -2.21% | -2.08% | -2.00% | -1.95% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -40.73% | -0.55% | -0.84% | -4.17% | 5.97% |
| Total Liabilities | -8.66% | -0.88% | 0.35% | 3.70% | -2.54% |
|
|
|||||
| Common Stock & APIC | 0.90% | 2.97% | 0.91% | 1.10% | 2.89% |
| Retained Earnings | -4.18% | -7.22% | -7.80% | -8.40% | -8.95% |
| Treasury Stock & Other | -8.18% | -62.55% | 285.85% | -23.00% | -283.82% |
| Total Common Equity | -4.03% | -2.98% | -6.87% | -6.34% | -2.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.03% | -2.98% | -6.87% | -6.34% | -2.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.03% | -2.98% | -6.87% | -6.34% | -2.74% |
|
|
|||||